How to Calculate 5-Amino-1MQ Concentration — Lab Protocol

Most researchers purchasing lyophilised 5-amino-1MQ assume the stated vial weight equals usable peptide mass. It doesn't. Manufacturing variability, residual moisture, and counter-ion mass can shift actual peptide content by 8–15%. Enough to compromise dosing accuracy across an entire study. A 50mg vial label represents approximate fill weight, not verified active compound mass. Research-grade peptide suppliers like Real Peptides provide Certificates of Analysis (CoA) with HPLC-verified purity percentages for exactly this reason. The CoA purity figure is the correction factor that converts nominal weight into actual peptide mass.

Our team has guided hundreds of researchers through peptide reconstitution protocols. The gap between protocol accuracy and real-world dosing error comes down to three calculations most guides gloss over: correcting for purity, converting mass to moles, and accounting for solvent volume displacement.

How do you calculate 5-amino-1MQ concentration from lyophilised powder?

To calculate 5-amino-1MQ concentration accurately, multiply the vial's stated peptide mass by the purity percentage from the Certificate of Analysis to determine actual peptide mass, then divide by the molecular weight (176.22 g/mol) to get moles. Divide moles by the final reconstitution volume in litres to yield molarity (mol/L), or multiply by 1000 to express concentration in millimolar (mM). A 50mg vial at 98% purity reconstituted in 5mL bacteriostatic water yields 55.7mM.

Yes, you need the purity correction. But that correction only matters if you're accounting for molecular weight properly. 5-Amino-1MQ (NNMT inhibitor, CAS 42464-96-0) has a molecular weight of 176.22 g/mol as the free base. Most suppliers ship the compound as a lyophilised powder with residual TFA (trifluoroacetic acid) salts from HPLC purification, which adds ~10–15% to the stated mass without contributing to pharmacological activity. This article covers how to calculate final molarity from vial mass, how to verify accuracy with gravimetric measurement, and what reconstitution mistakes invalidate the entire calculation.

Step 1: Verify Actual Peptide Mass Using CoA Purity

The first calculation step to calculate 5-amino-1MQ concentration is determining the actual peptide mass in the vial. Not the fill weight printed on the label. Lyophilised peptides are hygroscopic and retain 2–8% residual moisture even under proper storage at −20°C. Additionally, peptide synthesis leaves counter-ions (typically TFA salts) that contribute mass without pharmacological activity. The Certificate of Analysis from the supplier provides an HPLC-verified purity percentage. This is the correction factor.

Calculation: Actual Peptide Mass (mg) = Stated Vial Mass (mg) × (Purity % ÷ 100)

Example: A 50mg vial with 98% purity contains 50 × 0.98 = 49mg of active 5-amino-1MQ. If you skip this correction and assume 50mg, your calculated molarity will be 2% higher than reality. Compounding across dose escalation studies.

Gravimetric verification adds another layer: weigh the sealed vial, record the tare weight, reconstitute the peptide, then weigh the empty vial after drying under vacuum for 24 hours. The mass difference should match the CoA-adjusted peptide mass within ±3%. Discrepancies beyond this suggest either moisture absorption during handling or incomplete lyophilisation. We've found that peptides stored longer than 12 months at −20°C can gain 4–6% mass from moisture reabsorption even in sealed vials. The CoA purity remains valid, but the fill weight drifts.

Real Peptides provides third-party HPLC verification on every batch, with purity results included in the product documentation. This isn't standard across all research peptide suppliers. Some provide purity 'estimates' rather than verified assay data, which introduces unquantifiable error into downstream concentration calculations.

Step 2: Convert Mass to Moles Using Molecular Weight

Once you've determined actual peptide mass, the next step to calculate 5-amino-1MQ concentration is converting that mass into moles. 5-Amino-1MQ has a molecular weight of 176.22 g/mol (free base). The molecular formula is C₉H₁₂N₂O₂. This molecular weight is fixed and does not vary by supplier or synthesis method.

Calculation: Moles = Actual Peptide Mass (mg) ÷ Molecular Weight (g/mol) ÷ 1000

The division by 1000 converts milligrams to grams. Example: 49mg ÷ 176.22 g/mol ÷ 1000 = 0.000278 mol = 0.278 mmol.

This step is where most procedural guides introduce error by failing to specify whether the molecular weight accounts for salt forms. Many peptides are shipped as acetate, hydrochloride, or TFA salts. These add 60–114 g/mol to the molecular weight depending on the counter-ion. For 5-amino-1MQ, suppliers typically ship the free base rather than a salt form, but always verify the CoA molecular weight field. If the CoA lists a molecular weight above 180 g/mol, the compound contains residual salt mass. Adjust your calculation accordingly.

Molar concentration (molarity, mol/L) is the standard unit for enzyme kinetics, receptor binding assays, and dose-response curves because it directly reflects the number of molecules per unit volume. Using mg/mL or µg/mL without converting to molarity makes cross-study comparisons impossible when comparing peptides of different molecular weights.

Step 3: Divide by Reconstitution Volume to Calculate Molarity

The final step to calculate 5-amino-1MQ concentration is dividing moles by the reconstitution volume in litres. This yields molarity (mol/L), which can be converted to millimolar (mM) by multiplying by 1000.

Calculation: Molarity (M) = Moles ÷ Volume (L)

Example: 0.000278 mol ÷ 0.005 L = 0.0556 M = 55.6 mM.

Most protocols reconstitute in bacteriostatic water (0.9% benzyl alcohol) or sterile saline. Standard reconstitution volumes for a 50mg vial range from 2mL (yielding ~140mM) to 10mL (yielding ~28mM). Higher concentrations reduce injection volume but increase viscosity and precipitation risk. 5-amino-1MQ remains fully soluble in aqueous solution up to approximately 100mM at room temperature, but solubility drops below 10mM at 4°C, so refrigerated stocks should be prepared at ≥20mM to prevent crystallisation.

One critical nuance: peptide powder displaces solvent volume when dissolved. A 50mg peptide has an approximate density of 1.2–1.4 g/mL, meaning it displaces ~0.035–0.040mL when fully dissolved. For reconstitution volumes above 5mL, this displacement is negligible (<1% error). For volumes below 2mL, the displacement becomes significant. If you add 1.0mL of solvent to a 50mg vial, the final solution volume is approximately 1.035–1.040mL, not 1.000mL. To calculate 5-amino-1MQ concentration with high precision in low-volume reconstitutions, measure the final solution volume gravimetrically rather than assuming the added solvent volume equals final volume.

Our experience shows that researchers preparing serial dilutions for dose-response assays often skip this displacement correction and consequently underestimate concentration by 3–5% at the stock solution level. An error that propagates through every subsequent dilution.

5-Amino-1MQ Concentration: Calculation Comparison

Key Takeaways

• To calculate 5-amino-1MQ concentration, multiply vial mass by CoA purity percentage to determine actual peptide mass before any other calculation.
• 5-Amino-1MQ has a molecular weight of 176.22 g/mol as the free base. Divide actual peptide mass (in mg) by 176.22 and then by 1000 to convert to moles.
• Divide moles by reconstitution volume in litres to yield molarity (mol/L), or multiply by 1000 to express as millimolar (mM).
• Peptide powder displaces solvent volume when dissolved. For reconstitution volumes below 2mL, measure final volume gravimetrically to avoid 3–5% concentration underestimation.
• Standard reconstitution volumes range from 2–10mL for a 50mg vial, yielding concentrations between 28–139mM depending on intended use.
• Refrigerated stocks below 10mM risk peptide crystallisation. Prepare working stocks at ≥20mM when storing at 2–8°C.
• Gravimetric verification (weighing the vial before and after reconstitution) confirms the calculated mass matches actual peptide content within ±3%.

What If: 5-Amino-1MQ Concentration Scenarios

What If the CoA Purity Is Below 95% — Should I Adjust the Calculation?

Yes, adjust using the exact purity percentage provided. Purity below 95% is acceptable for preliminary screening work but should prompt a conversation with the supplier about batch quality. Calculate actual peptide mass as Vial Mass × (Purity ÷ 100). A 50mg vial at 92% purity contains 46mg active compound, yielding a final concentration 8% lower than assumed if you skip this correction. Lower purity also means higher impurity load. Primarily residual TFA salts and truncated peptide fragments. Which can interfere with receptor binding assays or enzymatic activity measurements.

What If I'm Preparing Serial Dilutions — Do I Recalculate for Each Step?

Recalculate only if you're verifying final well concentrations for publication. For internal dose-response work, calculate the stock concentration once, then apply standard dilution factors (C₁V₁ = C₂V₂). Example: a 55.6mM stock diluted 1:10 yields 5.56mM, diluted 1:100 yields 0.556mM. Pipetting error (±2–5% per transfer) compounds faster than calculation error in serial dilutions. Use calibrated pipettes and reverse-pipetting technique for viscous solutions above 50mM. The biggest mistake we see in serial dilution protocols is failing to mix thoroughly between steps. 5-amino-1MQ solutions above 20mM exhibit slight viscosity, and incomplete mixing leaves concentration gradients that skew IC₅₀ calculations by 10–15%.

What If the Reconstituted Solution Looks Cloudy — Is the Concentration Calculation Still Valid?

No. Cloudiness indicates incomplete solubilisation or precipitation, meaning the calculated concentration no longer reflects the dissolved peptide concentration. Some fraction is suspended as insoluble aggregates. This occurs when reconstituting above the solubility ceiling (~100mM at 25°C, ~60mM at 4°C) or when using solvents with incompatible pH. 5-Amino-1MQ is most soluble in neutral to slightly acidic pH (6.0–7.4). If cloudiness appears, warm the vial to 37°C for 5 minutes with gentle agitation. If it clears, the peptide was temporarily supersaturated and is now fully dissolved. If cloudiness persists, dilute the solution with additional solvent and recalculate concentration.

What If I Need to Calculate Concentration in µg/mL Instead of Molarity?

Convert molarity to µg/mL by multiplying by molecular weight and 1000. Example: 55.6mM × 176.22 g/mol × 1000 = 9,798 µg/mL ≈ 9.8 mg/mL. This conversion is common for in vivo dosing protocols where injection volumes are specified in µL/g body weight. However, using mass-based units (µg/mL) instead of molar units (mM) obscures the relationship between dose and receptor occupancy. Always report both units in published methods sections. The NIH guidelines for peptide research recommend primary reporting in molarity with mass concentration provided parenthetically.

The Unvarnished Truth About 5-Amino-1MQ Concentration Calculations

Here's the honest answer: most concentration errors don't come from the math. They come from skipping the purity correction and assuming the vial label reflects usable peptide. A 50mg vial at 95% purity contains 47.5mg, not 50mg. If you reconstitute assuming 50mg and calculate 5-amino-1MQ concentration from that figure, every downstream dilution, every reported IC₅₀, and every dose-response curve is systematically biased by 5%. This compounds when comparing results across labs using different suppliers with different purity thresholds. The CoA exists to eliminate this variability. Ignoring it because 'the difference is small' is how replication crises start. The second most common error is using the wrong molecular weight because the researcher didn't verify whether the compound was shipped as a free base or a salt. Verify both figures from the CoA before calculating anything.

Precision starts before the pipette. It starts with reading the Certificate of Analysis.

When your research demands peptides with verified purity and transparent documentation, our dedication to small-batch synthesis and exact amino-acid sequencing ensures the numbers on the CoA match what's in the vial. You can explore our Real Peptides collection, and see how precision in sourcing translates to precision in your results. Because concentration calculations are only as accurate as the peptide purity you start with.